700 related articles for article (PubMed ID: 22884251)
1. Removal of increased circulating CD4+CD25+Foxp3+ regulatory T cells in patients with septic shock using hemoperfusion with polymyxin B-immobilized fibers.
Ono S; Kimura A; Hiraki S; Takahata R; Tsujimoto H; Kinoshita M; Miyazaki H; Yamamoto J; Hase K; Saitoh D
Surgery; 2013 Feb; 153(2):262-71. PubMed ID: 22884251
[TBL] [Abstract][Full Text] [Related]
2. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K
Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068
[TBL] [Abstract][Full Text] [Related]
3. Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber.
Ono S; Tsujimoto H; Matsumoto A; Ikuta S; Kinoshita M; Mochizuki H
Am J Surg; 2004 Aug; 188(2):150-6. PubMed ID: 15249240
[TBL] [Abstract][Full Text] [Related]
4. Effects of hemoperfusion with an immobilized polymyxin-B fiber column on cytokine plasma levels in patients with abdominal sepsis.
Zagli G; Bonizzoli M; Spina R; Cianchi G; Pasquini A; Anichini V; Matano S; Tarantini F; Di Filippo A; Maggi E; Peris A
Minerva Anestesiol; 2010 Jun; 76(6):405-12. PubMed ID: 20473253
[TBL] [Abstract][Full Text] [Related]
5. Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock.
Tsujimoto H; Ono S; Hiraki S; Majima T; Kawarabayashi N; Sugasawa H; Kinoshita M; Hiraide H; Mochizuki H
J Endotoxin Res; 2004; 10(4):229-37. PubMed ID: 15373966
[TBL] [Abstract][Full Text] [Related]
6. Apheresis of activated leukocytes with an immobilized polymyxin B filter in patients with septic shock.
Kumagai T; Takeyama N; Yabuki T; Harada M; Miki Y; Kanou H; Inoue S; Nakagawa T; Noguchi H
Shock; 2010 Nov; 34(5):461-6. PubMed ID: 20386499
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of polymyxin-B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy.
Berto P; Ronco C; Cruz D; Melotti RM; Antonelli M
Blood Purif; 2011; 32(4):331-40. PubMed ID: 22086346
[TBL] [Abstract][Full Text] [Related]
8. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
Uriu K; Osajima A; Hiroshige K; Watanabe H; Aibara K; Inada Y; Segawa K; Anai H; Takagi I; Ito A; Kamochi M; Kaizu K
Am J Kidney Dis; 2002 May; 39(5):937-47. PubMed ID: 11979337
[TBL] [Abstract][Full Text] [Related]
9. Polymyxin B-immobilized fiber hemoperfusion attenuates increased plasma atrial natriuretic peptide and brain natriuretic Peptide levels in patients with septic shock.
Nakamura T; Suzuki T; Kawagoe Y; Koide H
ASAIO J; 2008; 54(2):210-3. PubMed ID: 18356658
[TBL] [Abstract][Full Text] [Related]
10. Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion.
Nakamura T; Sugaya T; Koide H
Shock; 2009 May; 31(5):454-9. PubMed ID: 18838948
[TBL] [Abstract][Full Text] [Related]
11. Suppression of high-mobility group box-1 and receptor for advanced glycation end-product axis by polymyxin B-immobilized fiber hemoperfusion in septic shock patients.
Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Maeda S; Yamagishi S
J Crit Care; 2011 Dec; 26(6):546-9. PubMed ID: 21273029
[TBL] [Abstract][Full Text] [Related]
12. Changes in plasma interleukin-18 by direct hemoperfusion with polymyxin B-immobilized fiber in patients with septic shock.
Nakamura T; Kawagoe Y; Suzuki T; Shoji H; Ueda Y; Kobayashi N; Koide H
Blood Purif; 2005; 23(6):417-20. PubMed ID: 16141713
[TBL] [Abstract][Full Text] [Related]
13. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity.
Kojika M; Sato N; Yaegashi Y; Suzuki Y; Suzuki K; Nakae H; Endo S
Ther Apher Dial; 2006 Feb; 10(1):12-8. PubMed ID: 16556131
[TBL] [Abstract][Full Text] [Related]
14. [Polymyxin-B direct hemoperfusion (PMX-DHP) in gram negative sepsis].
Perego AF; Morabito S; Graziani G; Casella GP; Parodi O
G Ital Nefrol; 2006; 23 Suppl 36():S94-102. PubMed ID: 17068736
[TBL] [Abstract][Full Text] [Related]
15. Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients.
Sakamoto Y; Mashiko K; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
ASAIO J; 2007; 53(3):324-8. PubMed ID: 17515723
[TBL] [Abstract][Full Text] [Related]
16. Increased proportion of CD4(+)CD25(+)Foxp3(+) regulatory T cells during early-stage sepsis in ICU patients.
Leng FY; Liu JL; Liu ZJ; Yin JY; Qu HP
J Microbiol Immunol Infect; 2013 Oct; 46(5):338-44. PubMed ID: 22921804
[TBL] [Abstract][Full Text] [Related]
17. Selection of hemoperfusion therapy for patients with septic shock on the basis of the primary disease.
Kanno Y; Nemoto H; Nakamoto H; Okada H; Sugahara S; Nishidome K; Yamashita Y; Suzuki H
J Artif Organs; 2003; 6(3):205-10. PubMed ID: 14598105
[TBL] [Abstract][Full Text] [Related]
18. Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock.
Kase Y; Obata T; Okamoto Y; Iwai K; Saito K; Yokoyama K; Takinami M; Tanifuji Y
Ther Apher Dial; 2008 Oct; 12(5):374-80. PubMed ID: 18937720
[TBL] [Abstract][Full Text] [Related]
19. A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock.
Mitaka C; Tsuchida N; Kawada K; Nakajima Y; Imai T; Sasaki S
Shock; 2009 Nov; 32(5):478-83. PubMed ID: 19295483
[TBL] [Abstract][Full Text] [Related]
20. Clinical Effects of a Longer Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Therapy for Severe Sepsis and Septic Shock.
Yamashita C; Hara Y; Kuriyama N; Nakamura T; Nishida O
Ther Apher Dial; 2015 Aug; 19(4):316-23. PubMed ID: 26386218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
